Compound UNI418 disrupts cancer DNA repair to overcome drug resistance
A good honest bake. Not flashy, but you'll finish the whole bagel.
Summary
Researchers have discovered that cancer cells survive DNA-damaging treatments by using sophisticated repair systems like homologous recombination, which relies on proteins such as RAD51 and CHK1. PARP inhibitors were designed to exploit these weaknesses, but cancers often adapt by restoring their repair capabilities. The compound UNI418 can disrupt this repair ability, and when combined with a PARP inhibitor, it helps resistant cancer cells respond to treatment again, offering a new strategy for overcoming drug resistance.
Key quotes
· 5 pulledCancer cells have a remarkable ability to survive treatments that damage their DNA.
Among the most important of these systems is homologous recombination, a highly accurate DNA repair process that depends on proteins such as RAD51 and CHK1.
Cancer therapies known as PARP inhibitors were designed to exploit weaknesses in DNA repair.
By restoring their DNA repair capabilities, they become resistant to further treatment.
The findings point to a new strategy for overcoming cancer drug resistance.
You might also wanna read
New CRISPR Technique Selectively Destroys Cancer Cells with Common Mutation
Researchers at UC Berkeley, UCSF, and Gladstone Institutes have developed a novel CRISPR-based technique called "RNA-Triggered Chromatin Shr
innovativegenomics.org·3d ago
Promising pancreatic cancer drug may unlock new class of treatments targeting cancer's master switch
The article discusses a promising new drug that targets pancreatic tumors and may have revealed a "master switch" for cancer. The treatment
economist.com·2d ago
Oregon State University Researchers Develop Iron Nanomaterial That Selectively Destroys Cancer Cells
Researchers at Oregon State University have developed a novel iron-based nanomaterial that targets and destroys cancer cells from within. Th
Spanish Researchers Develop Breakthrough Therapy Protocol for Pancreatic Cancer Treatment
Spanish researchers have developed a new therapy protocol that could revolutionize pancreatic cancer treatment. Pancreatic cancer is notorio
nypost.com·4mo ago